Integrated healthcare services organization Pear Therapeutics has announced the expansion of its collaboration with Spero Health, an integrated healthcare services organization that provides outpatient opioid treatment providers for individuals in recovery.
The partnership will provide adults suffering from substance use disorder (SUD) and opioid use disorder (OUD) access to reSET and reSET-O, for each respective condition.
Pear's reSET, a mobile application used to help treat substance use disorder, received FDA De Novo clearance in 2017 and reSET-O received 510(k) clearance in 2018.
reSET is used as a monotherapy for patients 18 years of age or older with substance use disorder and reSET-O is used in combination with buprenorphine-based medication- assisted treatment for patients 18 years of age or older with opioid use disorder.
Spero Health, which has implemented reSET and reSET-O at 14 locations in Kentucky, intends to expand access to eligible patients at its 99 locations throughout Indiana, Kentucky, Ohio, Tennessee, West Virginia, and Virginia.
Prescription digital therapeutics are an innovative class of treatments that use software to treat serious disease. Like traditional medicines, these products are evaluated and authorized by regulators like the Food and Drug Administration (FDA) and used under the supervision of a prescribing clinician. Unlike traditional medicines, they are designed to collect real world data that may be used by clinicians to inform treatment and by payers and health systems for population health management.
Join the HealthXL Webinar on ‘Retail Healthcare: Current and Future Opportunities for Digital Health’ on 26th January. Click here to Request to Join.
Click here to read the original news story.